Andrew Lovering

4.4k total citations · 1 hit paper
55 papers, 3.2k citations indexed

About

Andrew Lovering is a scholar working on Epidemiology, Pharmacology and Surgery. According to data from OpenAlex, Andrew Lovering has authored 55 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 21 papers in Pharmacology and 17 papers in Surgery. Recurrent topics in Andrew Lovering's work include Antibiotics Pharmacokinetics and Efficacy (21 papers), Orthopedic Infections and Treatments (16 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). Andrew Lovering is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (21 papers), Orthopedic Infections and Treatments (16 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). Andrew Lovering collaborates with scholars based in United Kingdom, United States and France. Andrew Lovering's co-authors include Alastair D Hay, Céire Costelloe, Chris Metcalfe, David Mant, Herbert Gbejuade, Jason Webb, Alasdair MacGowan, Alison H. Thomson, C. M. Tobin and Robert F. Spencer and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Andrew Lovering

55 papers receiving 3.1k citations

Hit Papers

Effect of antibiotic prescribing in primary care on antim... 2010 2026 2015 2020 2010 400 800 1.2k

Peers

Andrew Lovering
Comparison fields: 5 of 147
  • Applied Microbiology and Biotechnology 1.1k
  • Epidemiology 1.0k
  • Surgery 658
  • Infectious Diseases 557
  • Pharmacology 539
Inge C. Gyssens Netherlands
Jason G. Newland United States
Kirsty Buising Australia
J. E. McGowan United States
Lennox K. Archibald United States
Maureen Bolon United States
R.A. Seaton United Kingdom
Lindsey M. Weiner United States
Andrew M. Morris Canada
Håkan Hanberger Sweden
Inge C. Gyssens Netherlands View profile →
Citations per field, relative to Andrew Lovering
Andrew Lovering · 1×
Citations per year, relative to Andrew Lovering
Andrew Lovering · 1×

Countries citing papers authored by Andrew Lovering

Since Specialization
Citations

This map shows the geographic impact of Andrew Lovering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lovering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lovering more than expected).

Fields of papers citing papers by Andrew Lovering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Lovering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lovering. The network helps show where Andrew Lovering may publish in the future.

Co-authorship network of co-authors of Andrew Lovering

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Lovering. A scholar is included among the top collaborators of Andrew Lovering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Lovering. Andrew Lovering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Susceptibility of monomicrobial or polymicrobial biofilms derived from infected diabetic foot ulcers to topical or systemic antibiotics in vitro PLoS ONE Robert Morley, Frank L. Bowling et al. 25
2 Anin vitrobiofilm model ofStaphylococcus aureusinfection of bone Letters in Applied Microbiology Andrew Lovering, Karen E. Bowker et al. 14
3 Microneedle biosensors for real-time, minimally invasive drug monitoring of phenoxymethylpenicillin: a first-in-human evaluation in healthy volunteers The Lancet Digital Health Timothy M. Rawson, Sally A. N. Gowers et al. 131
4 Linezolid and lactation: measurement of drug levels in breast milk and the nursing infant Journal of Antimicrobial Chemotherapy Andrew Lovering, Andrew Currie et al. 3
5 Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection Antimicrobial Agents and Chemotherapy Andrew Lovering, Frank L. Bowling et al. 39
6 Therapeutic drug monitoring in the past 40 years of the Journal of Antimicrobial Chemotherapy Journal of Antimicrobial Chemotherapy David Reeves, Andrew Lovering et al. 24
7 Impact of soaking gentamicin-containing collagen implants on potential antimicrobial efficacy International Journal of Surgery Andrew Lovering et al. 15
8 Effect of antibiotic prescribing in primary care on meticillin-resistant Staphylococcus aureus carriage in community-resident adults: a controlled observational study International Journal of Antimicrobial Agents Céire Costelloe, Andrew Lovering et al. 22
9 Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis breakdown → BMJ Céire Costelloe, Chris Metcalfe et al. 1454
10 Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations Journal of Antimicrobial Chemotherapy Alison H. Thomson, Christine E. Staatz et al. 120
11 Pharmacokinetic evaluation of linezolid in patients with major thermal injuries Journal of Antimicrobial Chemotherapy Andrew Lovering, R. Le Floch et al. 29
12 Development, evaluation and application of an isocratic high-performance liquid chromatography (HPLC) assay for the simultaneous determination of aciclovir and its metabolite 9-carboxymethoxymethylguanine in human serum and cerebrospinal fluid International Journal of Antimicrobial Agents J. M. Darville, Andrew Lovering et al. 7
13 Problems of basing patient recruitment for primary care studies on routine laboratory submissions: Table 1 Journal of Clinical Pathology Cliodna McNulty, Mike Thomas et al. 4
14 Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory International Journal of Antimicrobial Agents Mehnam Soltani, C. M. Tobin et al. 28
15 Assay of ertapenem in human serum by high-performance liquid chromatography International Journal of Antimicrobial Agents Mehnam Soltani, Alasdair MacGowan et al. 12
16 A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces International Journal of Antimicrobial Agents Andrew Lovering, C. M. Tobin et al. 23
17 Epidemiology and resource utilization for patients hospitalized for lower respiratory tract infection Clinical Microbiology and Infection Andrew Lovering, Alasdair MacGowan et al. 11
18 The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone Journal of Antimicrobial Chemotherapy Andrew Lovering 24
19 Difficulties in the assay of liposomal amikacin (MiKasome) in serum Journal of Antimicrobial Chemotherapy Andrew Lovering 2
20 Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for Antibiotic Assays meeting for participants, October 1993 Journal of Antimicrobial Chemotherapy D. S. Reeves, Alasdair MacGowan et al. 15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026